JP2014527073A5 - - Google Patents

Download PDF

Info

Publication number
JP2014527073A5
JP2014527073A5 JP2014530158A JP2014530158A JP2014527073A5 JP 2014527073 A5 JP2014527073 A5 JP 2014527073A5 JP 2014530158 A JP2014530158 A JP 2014530158A JP 2014530158 A JP2014530158 A JP 2014530158A JP 2014527073 A5 JP2014527073 A5 JP 2014527073A5
Authority
JP
Japan
Prior art keywords
alkyl
halogen
group
alkoxy
unsubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014530158A
Other languages
English (en)
Japanese (ja)
Other versions
JP5815874B2 (ja
JP2014527073A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2012/067469 external-priority patent/WO2013037703A1/en
Publication of JP2014527073A publication Critical patent/JP2014527073A/ja
Publication of JP2014527073A5 publication Critical patent/JP2014527073A5/ja
Application granted granted Critical
Publication of JP5815874B2 publication Critical patent/JP5815874B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014530158A 2011-09-12 2012-09-07 Hdlコレステロール上昇剤としての3−ピリジンカルボン酸ヒドラジド Expired - Fee Related JP5815874B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11180929.9 2011-09-12
EP11180929 2011-09-12
PCT/EP2012/067469 WO2013037703A1 (en) 2011-09-12 2012-09-07 3 -pyridine carboxylic acid hydrazides as hdl-cholesterol raising agents

Publications (3)

Publication Number Publication Date
JP2014527073A JP2014527073A (ja) 2014-10-09
JP2014527073A5 true JP2014527073A5 (enExample) 2015-07-16
JP5815874B2 JP5815874B2 (ja) 2015-11-17

Family

ID=46796631

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014530158A Expired - Fee Related JP5815874B2 (ja) 2011-09-12 2012-09-07 Hdlコレステロール上昇剤としての3−ピリジンカルボン酸ヒドラジド

Country Status (10)

Country Link
US (1) US8648099B2 (enExample)
EP (1) EP2755953A1 (enExample)
JP (1) JP5815874B2 (enExample)
KR (1) KR20140057652A (enExample)
CN (1) CN103781765A (enExample)
BR (1) BR112014005634A2 (enExample)
CA (1) CA2844865A1 (enExample)
MX (1) MX2014001860A (enExample)
RU (1) RU2014111321A (enExample)
WO (1) WO2013037703A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107056749A (zh) * 2015-03-12 2017-08-18 佛山市赛维斯医药科技有限公司 一类含烟酸酰胺和哌啶结构ptp1b抑制剂及其用途
US20200085810A1 (en) * 2018-07-26 2020-03-19 Hoffmann-La Roche Inc. Compounds for use in treating kidney disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1492784A4 (en) * 2002-03-28 2006-03-29 Merck & Co Inc SUBSTITUTED 2,3-DIPHENYLPYRIDINES
ES2326280T3 (es) * 2005-04-06 2009-10-06 F. Hoffmann-La Roche Ag Derivados de piridin-3-carboxamida como agonistas inversos de cb1.
WO2007011760A2 (en) * 2005-07-15 2007-01-25 Kalypsys, Inc. Inhibitors of mitotic kinesin
US7629346B2 (en) * 2006-06-19 2009-12-08 Hoffmann-La Roche Inc. Pyrazinecarboxamide derivatives as CB1 antagonists
EP2074096B1 (en) * 2006-10-04 2012-06-27 F. Hoffmann-La Roche AG 3-pyridinecarboxamide and 2-pyrazinecarboxamide derivatives as hdl-cholesterol raising agents
TW200940537A (en) * 2008-02-26 2009-10-01 Astrazeneca Ab Heterocyclic urea derivatives and methods of use thereof

Similar Documents

Publication Publication Date Title
EA201690019A1 (ru) Производное аминотриазина и содержащая его фармацевтическая композиция
JP2012140432A5 (enExample)
JP2015143283A5 (enExample)
PE20160608A1 (es) Compuestos de quinolina selectivamente sustituida
JP2015537008A5 (enExample)
CY1119015T1 (el) 4'-αζιδο-3'φθορο υποκατεστημενα νουκλεοζιδιου παραγωγα ως αναστολεις αντιγραφης hcv rna
AR059622A1 (es) Quinolonas utiles como inhibidores de la sintetasa del oxido nitrico inducibles
EA201070872A1 (ru) Производные азабициклических карбоксамидов, их получение и их применение в терапии
EA201290260A1 (ru) Бензимидазол-имидазольные производные
AR092955A1 (es) Antagonistas de receptores de orexina los cuales son derivados de [orto bi-(hetero-)aril]-[2-(meta bi-(hetero-)aril)-pirrolidin-1-il]-metanona
JP2016540742A5 (enExample)
CO6150164A2 (es) Derivados de 2-metilmorfolina pirido-,pirazo-ypirimido-pirimidina como inhibidores de mtor
EA201690172A1 (ru) Полиморф ингибиторов syk
JP2016506958A5 (enExample)
JP2010504286A5 (enExample)
JO3734B1 (ar) -n[5-(أمينوسلفونيل)-4- ميثيل-3،1- ثيازول-2- يل]-n- ميثيل-2-[4-(2- بيريدينيل) فنيل] أسيتاميد ميسيلات مونوهيدرات
EA201071012A1 (ru) Производные азетидинов, способ их получения и применение их в терапии
EA201791816A1 (ru) Ингибиторы kv1.3 и их применение в медицине
EA201490754A1 (ru) Производные карбамата/мочевины, содержащие пиперидиновые и пиперазиновые кольца, в качестве ингибиторов н3 рецептора
MA38078B1 (fr) Dérivé de pyridine
JP2016531950A5 (ja) 複素環化合物
RU2017102513A (ru) Соль гетероциклического соединения, замещенного галогеном
CY1116388T1 (el) 5-(φαινυλο/πυριδινυλο-αιθινυλο)-2-πυριδινο/2-πυριμιδινο-καρβοξαμιδια ως mglur5 ρυθμιστες
JP2016500653A5 (enExample)
EA201590069A1 (ru) Пиримидиноновые производные в качестве антималярийных средств